Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lodge, P. A.
Right arrow Articles by Sriram, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lodge, P. A.
Right arrow Articles by Sriram, S.
NEUROLOGY 1996;46:1410
© 1996 American Academy of Neurology

Frequency of MBP and MBP peptide-reactive T cells in the HPRT mutant T-cell population of MS patients

Patricia A. Lodge, PhD, Chad Johnson, BS and Subramaniam Sriram, MBBS

Department of Neurology, Vanderbilt University, Nashville, TN.

Address correspondence and reprint requests to Dr. Patricia A. Lodge, Multiple Sclerosis Research Laboratory, Room 1222, Vanderhilt Stallworth Rehahilitation Hospital, 2201 Capers Ave, Nashville, TN 37212.

Somatic mutation as an index of in vivo T-cell amplification is a powerful tool to analyze the specificity and size of the autoreactive T-cell repertoire. Using this strategy, we determined the precursor frequency of T cells reactive to myelin basic protein (MBP) and overlapping MBP peptides spanning regions p84-168 in patients with MS and controls in the HPRT mutant T-cell population. Among 19 MS patients, nine had estimatable frequencies to MBP or MBP peptides, p93-112, p124-142 and p143-168 in the HPRT mutant T-cell population. Only one of the 10 controls showed measurable frequency to MBP in the HPRT mutant T-cell population. These studies suggest that increased frequency of T cells reactive to MBP and MBP peptides might indicate putative disease-related epitopes in MS.


Received April 28, 1995. Accepted in final form July 12, 1995.




This article has been cited by other articles:


Home page
JAMAHome page
D. R. Smith and H. L. Weiner
Immunologic Aspects of Neurologic and Neuromuscular Diseases
JAMA, December 10, 1997; 278(22): 1956 - 1961.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by AAN Enterprises, Inc.